Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.40+0.00 (0.00%)
Close on Nov 12, 2026Market cap $242.26MP/E –Yield –
Lifecore Biomedical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Lifecore Biomedical's ebitda for the twelve months ending May 25, 2025 was -$9.22M. For fiscal 2025 it was -$9.22M. The highest annual figure on record is $32.16M in fiscal 2013.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | May 25, 2025 | -$9.22M | – |
| FY2024 | May 26, 2024 | -$890.00K | – |
| FY2023 | May 28, 2023 | -$8.62M | -237.5% |
| FY2022 | May 29, 2022 | $6.27M | -43.2% |
| FY2021 | May 30, 2021 | $11.04M | – |
| FY2020 | May 31, 2020 | -$7.04M | -134.0% |
| FY2019 | May 26, 2019 | $20.71M | -20.4% |
| FY2018 | May 27, 2018 | $26.00M | +2.6% |
| FY2017 | May 28, 2017 | $25.35M | – |
| FY2016 | May 29, 2016 | -$11.23M | -144.0% |
| FY2015 | May 31, 2015 | $25.55M | -6.4% |
| FY2014 | May 25, 2014 | $27.30M | -15.1% |
| FY2013 | May 26, 2013 | $32.16M | +59.2% |
| FY2012 | May 27, 2012 | $20.20M | +51.4% |
| FY2011 | May 29, 2011 | $13.35M | +17.6% |
| FY2010 | May 30, 2010 | $11.35M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ2 2025 | May 25, 2025 | $7.24M | +73.9% |
| Q3 FY2025CQ1 2025 | Feb 23, 2025 | -$6.95M | -725.8% |
| Q2 FY2025CQ4 2024 | Nov 24, 2024 | $85.00K | -83.1% |
| Q1 FY2025CQ3 2024 | Aug 25, 2024 | -$9.59M | – |
| Q4 FY2024CQ2 2024 | May 26, 2024 | $4.16M | – |
| Q3 FY2024CQ1 2024 | Feb 25, 2024 | $1.11M | – |
| Q2 FY2024CQ4 2023 | Nov 26, 2023 | $504.00K | – |
| Q1 FY2024CQ3 2023 | Aug 27, 2023 | -$6.45M | -696.9% |
| Q4 FY2023CQ2 2023 | May 28, 2023 | -$3.97M | -496.4% |
| Q3 FY2023CQ1 2023 | Feb 26, 2023 | -$3.32M | – |
| Q2 FY2023CQ4 2022 | Nov 27, 2022 | -$2.41M | -125.1% |
| Q1 FY2023CQ3 2022 | Aug 28, 2022 | $1.08M | +28.3% |
| Q4 FY2022CQ2 2022 | May 29, 2022 | $1.00M | – |
| Q3 FY2022CQ1 2022 | Feb 27, 2022 | -$6.09M | -220.4% |
| Q2 FY2022CQ4 2021 | Nov 28, 2021 | $9.62M | +57.7% |
| Q1 FY2022CQ3 2021 | Aug 29, 2021 | $842.00K | – |
| Q4 FY2021CQ2 2021 | May 30, 2021 | -$1.57M | -134.3% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $5.06M | – |
| Q2 FY2021CQ4 2020 | Nov 29, 2020 | $6.10M | – |
| Q1 FY2021CQ3 2020 | Aug 30, 2020 | -$5.50M | -4571.5% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $4.59M | -36.3% |
| Q3 FY2020CQ1 2020 | Feb 23, 2020 | -$10.24M | -240.5% |
| Q2 FY2020CQ4 2019 | Nov 24, 2019 | -$1.51M | -145.4% |
| Q1 FY2020CQ3 2019 | Aug 25, 2019 | $123.00K | -95.7% |
| Q4 FY2019CQ2 2019 | May 26, 2019 | $7.20M | -36.9% |
| Q3 FY2019CQ1 2019 | Feb 24, 2019 | $7.29M | +10.0% |
| Q2 FY2019CQ4 2018 | Nov 25, 2018 | $3.32M | +45.4% |
| Q1 FY2019CQ3 2018 | Aug 26, 2018 | $2.89M | -49.1% |
| Q4 FY2018CQ2 2018 | May 27, 2018 | $11.41M | +156.1% |
| Q3 FY2018CQ1 2018 | Feb 25, 2018 | $6.63M | -5.9% |
| Q2 FY2018CQ4 2017 | Nov 26, 2017 | $2.29M | -60.7% |
| Q1 FY2018CQ3 2017 | Aug 27, 2017 | $5.68M | -29.2% |
| Q4 FY2017CQ2 2017 | May 28, 2017 | $4.46M | -51.4% |
| Q3 FY2017CQ1 2017 | Feb 26, 2017 | $7.05M | – |
| Q2 FY2017CQ4 2016 | Nov 27, 2016 | $5.81M | – |
| Q1 FY2017CQ3 2016 | Aug 28, 2016 | $8.02M | – |
| Q4 FY2016CQ2 2016 | May 29, 2016 | $9.16M | – |
See a number that looks wrong?